Investigating a new dosing method for treating pediatric lupus nephritis
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
This study is looking at how to make treatment better for kids with lupus kidney disease by comparing two ways of giving a medication called mycophenolate mofetil (MMF) to see which one helps their kidneys work better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11077820 on NIH RePORTER |
What this research studies
This research focuses on improving the treatment of pediatric proliferative lupus nephritis by comparing two different dosing methods of the medication mycophenolate mofetil (MMF). One method is based on standard weight or body-surface-area calculations, while the other uses a pharmacokinetically-guided approach that tailors the dose to individual patient needs. The study will involve a randomized, double-blind controlled trial over 104 weeks, aiming to determine which method leads to better kidney health outcomes in children. Participants will be monitored for their response to treatment, specifically looking for improvements in kidney function.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with proliferative lupus nephritis who are between the ages of 0 and 11.
Not a fit: Patients who do not have lupus nephritis or are older than 11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for children with lupus nephritis, potentially improving their kidney health and overall quality of life.
How similar studies have performed: Previous research in adults has shown promising results with similar pharmacokinetically-guided dosing approaches, suggesting potential for success in pediatric populations.
Where this research is happening
Cincinnati, United States
- Cincinnati Childrens Hosp Med Ctr — Cincinnati, United States (Active)
Researchers
- Principal investigator: Brunner, Hermine I — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Brunner, Hermine I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.